Reshma Kewalramani, Vertex CEO (Barry Chin/The Boston Globe via Getty Images)

Ver­tex strikes $4.9B deal for Alpine, ex­pand­ing work in kid­ney and au­toim­mune dis­ease

Resh­ma Ke­wal­ra­mani is putting Ver­tex’s $10 bil­lion-plus bal­ance sheet to work.

On Wednes­day, the biotech an­nounced it would pay $4.9 bil­lion …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.